Literature DB >> 30835853

Mesenchymal stromal cells modulate tissue repair responses within the injured vocal fold.

Srinivasa Rao Nagubothu1, Rachael V Sugars2, Nikolce Tudzarovski2, Anton Törnqvist Andrén1, Matteo Bottai3, Lindsay C Davies1, Stellan Hertegård4,5, Katarina Le Blanc1,6.   

Abstract

OBJECTIVES/HYPOTHESIS: This study aimed to determine whether local injection of human mesenchymal stromal cells (MSC) could modulate the early inflammatory response within injured vocal folds (VFs) to promote wound-healing processes. STUDY
DESIGN: Experimental xenograft model.
METHODS: VF injury was surgically induced by bilateral resection of the lamina propria of rabbits, and MSC were immediately injected into the injured area of both VFs. Animals were sacrificed on days 2, 4, and 24. Histological analyses were performed by hematoxylin and eosin, Masson's Trichrome, and elastin staining. Cell death was visualized by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and the M2 macrophage marker, CD163, detected by immunohistochemistry. Persistence of injected MSC was evaluated by fluorescent in situ hybridization (FISH). Quantitative polymerase chain reaction was performed on the contralateral VF.
RESULTS: Histological examination at days 2 and 4 indicated that MSC were able to reduce tissue inflammation, with gene expression analysis confirming a significant reduction of proinflammatory markers, interleukin (IL)-1β, and IL-8. FISH demonstrated low-level persistence of injected MSC at both time points, and TUNEL confirmed localized cell death at the injury site. Increased levels of CD163+ anti-inflammatory macrophages indicated a change in the immune milieu, supporting wound resolution. Evidence of a more organized collagen matrix suggests that MSC may enhance the production of a functional repair tissue after injury, despite their low-level persistence within the tissue.
CONCLUSIONS: This study demonstrates that MSC are able to positively modulate the early wound-healing response through resolution of the inflammatory phase and promotion of tissue repair. LEVEL OF EVIDENCE: NA Laryngoscope, 130:E21-E29, 2020.
© 2019 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Vocal fold; cell therapy; immunomodulation; inflammation; mesenchymal stromal cells; wound healing

Mesh:

Year:  2019        PMID: 30835853     DOI: 10.1002/lary.27885

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  A xenograft study of human adipose stromal cell-based vocal fold mucosal replacement in rabbits.

Authors:  Eric K Tran; Yazeed Alhiyari; Kevin Juarez; Bhavani Shankara Gowda; Feng Schrader; Dipti P Sajed; Jennifer L Long
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-26

2.  Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells-first phase I/II human clinical study: commentary to response.

Authors:  Stellan Hertegård; Katarina LeBlanc
Journal:  Stem Cell Res Ther       Date:  2020-06-16       Impact factor: 6.832

3.  Magnetic targeting enhances the cutaneous wound healing effects of human mesenchymal stem cell-derived iron oxide exosomes.

Authors:  Xiuying Li; Ying Wang; Liyan Shi; Binxi Li; Jing Li; Zhenhong Wei; Huiying Lv; Liya Wu; Hao Zhang; Bai Yang; Xiaohua Xu; Jinlan Jiang
Journal:  J Nanobiotechnology       Date:  2020-08-14       Impact factor: 10.435

4.  Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells-first phase I/II human clinical study.

Authors:  Stellan Hertegård; Srinivasa Rau Nagubothu; Emma Malmström; Katarina LeBlanc
Journal:  Stem Cell Res Ther       Date:  2020-03-20       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.